CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill imprint CYP 517 has been identified as Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg.

Uritact-EC is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)

Uritact-EC
Generic Name:
hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint:
CYP 517
Strength:
0.06 mg-81.6 mg-10.8 mg-36.2 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cypress Pharmaceutical Inc

View Details Print Page

More about Uritact-EC (hyoscyamine / methenamine / methylene blue / phenyl salicylate)

Consumer resources

Compare with other treatments for:

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)